Close
Show
Home Press Releases

Press Releases

Press Releases is unique and effective promotional tool offered from Worldpharmatoday.com aimed at bringing our client’s business message into limelight and more importantly make it reach their target audience. This feature can be utilized to launch new product, promoting existing Pharma product, publish business agreements, annual reports, financial results, corporate performances, important announcements or any important information that has to be conveyed to the target audience.

Cipla receives final USFDA approval for generic version of Shire’s Firazyr


Cipla Limited announced that it has received final approval for its Abbreviated New Drug Application...

Merck Opens its Largest M Lab Collaboration Center in Shanghai


Merck, a leading science and technology company, opened its M LabTM Collaboration Center in Shanghai,...

Samsung Biologics and ImmuneOncia sign multi-product development and manufacturing agreement


Samsung Biologics and ImmuneOncia Therapeutics held a signing ceremony for a contract to develop and...

ChargePoint Technology and STERIS collaborate to offer fully validated sterile transfer solution


Powder containment and sterile transfer solutions experts, ChargePoint Technology, announced that it has entered into...
DCGI Nod for its Use in Moderate to Severe COVID-19 Patients

Biocon’s Breakthrough Drug Itolizumab Receives DCGI Nod for its Use in Moderate to Severe...


Biocon Ltd., an innovation-led global biopharmaceuticals company, announced that it has received the Drugs Controller...
Turkish Cargo keeps growing steadily

“CARGY”, the new digital solution partner by Turkish Cargo


Providing air cargo service to 127 countries worldwide, Turkish Cargo’s “CARGY”, the new artificial intelligence...

AbbVie : FDA Approves Expanded BOTOX Label for the Treatment of Pediatric Patients with...


Allergan, an AbbVie company, announced that the U.S. FDA approved a supplemental Biologics License Application...
Aigenpulse introduces novel data intelligence platform to life science markets

Aigenpulse introduces novel data intelligence platform to life science markets


Life science and data technology innovator, Aigenpulse,is introducing a new state of-the-art data intelligence platform...

Vetter Further Expands its Development Service with New Site in Austria


With biopharmaceutical development heavily focused on specialized therapeutics, drug sponsors are increasingly turning to expert...

AstraZeneca-Merck’s Lynparza wins EU approval for pancreatic cancer


AstraZeneca and MSD Inc., Kenilworth, N.J., US announced that Lynparza (olaparib) has been approved in...